Form 4: Enova CSO Granted Stock Options with SARs

Enova International's Chief Strategy Officer, Kirk Chartier, was granted 3,878 non-qualified stock options with limited stock appreciation rights.

Summary

• Kirk Chartier, Chief Strategy Officer of Enova International, Inc. (ENVA), was granted 3,878 non-qualified stock options with limited Stock Appreciation Rights (SARs).
• The transaction date for this grant was November 6, 2025.
• The exercise price for these options is $128 per share.
• The options will vest in three substantially equal annual increments on November 6, 2026, November 6, 2027, and November 6, 2028, provided the grantee remains an employee.
• The options have an expiration date of November 6, 2032.
• The limited SARs are exercisable only during a 30-day period following a 'Change in Control' of Enova International, as defined in the grant agreement.
• Upon SAR exercise, the grantee can receive an amount based on the 'Offer Value Per Share' exceeding the exercise price, multiplied by the number of shares, payable only if an 'Offer' is made.
• 'Offer Value Per Share' is defined as the average selling price of Enova's common stock over the 30 days ending on the SAR exercise date.
• 'Offer' refers to a tender or exchange offer for at least 30% of total voting power or an asset purchase of at least 40% of total gross fair market value of assets, excluding offers made by the Issuer.

Sentiment

Score: 6

Explanation: The filing reports a routine executive compensation grant, which is generally a neutral to slightly positive event as it aligns management incentives with shareholder value and aids in retention. There are no immediate negative implications for the company's operations or financial health.

Positives

• The grant of stock options and SARs aligns the Chief Strategy Officer's interests with those of shareholders, incentivizing long-term performance and value creation.
• The vesting schedule encourages executive retention over a three-year period, providing stability in leadership.

Risks

• The value realization from the limited Stock Appreciation Rights (SARs) is contingent on a 'Change in Control' event and a subsequent 'Offer,' introducing uncertainty regarding their potential payout.
• The definition of 'Offer' requires a significant tender/exchange offer (>=30% voting power) or asset purchase (>=40% gross fair market value), which are specific and not guaranteed events.

Future Outlook

The future outlook for the granted options is tied to the company's stock performance relative to the $128 exercise price and the Chief Strategy Officer's continued employment through the vesting dates of November 6, 2026, 2027, and 2028. The limited SARs' value realization is contingent on a future 'Change in Control' event and a qualifying 'Offer' for the company.

Industry Context

The grant of stock options and stock appreciation rights is a common form of executive compensation in the financial technology and lending industry, designed to attract, retain, and incentivize key management personnel by linking their compensation to the company's long-term performance and shareholder value.

Comparison to Industry Standards

• Executive equity grants, including stock options and SARs, are standard practice across publicly traded companies, particularly in the financial services and technology sectors, to align management incentives with shareholder interests.
• The vesting schedule of three years is typical for such grants, promoting long-term retention and performance focus, comparable to practices at peers like LendingClub or Upstart.
• The inclusion of limited SARs contingent on a 'Change in Control' is a specific feature that can be found in some executive compensation packages, often designed to provide a payout in specific M&A scenarios, though not universally applied across all companies.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon option exercise, but also benefit from increased alignment of executive incentives with long-term company performance.
• Employees (specifically Kirk Chartier): Receives a significant equity grant, providing a long-term incentive and potential wealth creation opportunity tied to company success and continued employment.

Next Steps

• The Chief Strategy Officer must remain an employee through November 6, 2026, 2027, and 2028 for the options to vest.
• The options can be exercised at any time after vesting and before the expiration date of November 6, 2032, assuming the stock price is above the exercise price.
• The limited SARs may become exercisable only if a 'Change in Control' event occurs, followed by a qualifying 'Offer'.

Key Dates

Keywords

Enova International, ENVA, Stock Options, SARs, Executive Compensation, Insider Transaction, Chief Strategy Officer, Equity Grant, Vesting, Change in Control